UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 374

Sortiert nach

The 4S-AF Scheme (Stroke Risk; Symptoms; Severity of Burden; Substrate): A Novel Approach to In-Depth Characterization (Rather than Classification) of Atrial Fibrillation

Thrombosis and haemostasis, 2021-03, Vol.121 (3), p.270

2021

Link zum Volltext

Verfügbarkeit prüfen

Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE

European journal of preventive cardiology, 2017-01, Vol.24 (1), p.41-69

2017

Link zum Volltext

Verfügbarkeit prüfen

2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Hea

Europace (London, England), 2019-02, Vol.21 (2), p.192-193

2019

Link zum Volltext

Verfügbarkeit prüfen

Atrial fibrillation history impact on catheter ablation outcome

Pacing and clinical electrophysiology, 2019-06, Vol.42 (6), p.759-759

2019

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement

Europace (London, England), 2013-09, Vol.15 (9), p.1337-1382

2013

Link zum Volltext

Verfügbarkeit prüfen

The wearable cardioverter-defibrillator: current technology and evolving indications

Europace (London, England), 2017-03, Vol.19 (3), p.335-345

2017

Link zum Volltext

Verfügbarkeit prüfen

Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE

Europace (London, England), 2017-01, Vol.19 (1), p.139-163

2017

Link zum Volltext

Verfügbarkeit prüfen

Thoracoscopic epicardial left atrial ablation in symptomatic patients with atrial fibrillation

Europace (London, England), 2016-10, Vol.18 (10), p.1538-1544

2016

Link zum Volltext

Verfügbarkeit prüfen

Programmed ventricular stimulation early after myocardial infarction: authors' reply

Europace (London, England), 2016-05, Vol.18 (5), p.789-790

2016

Link zum Volltext

Verfügbarkeit prüfen

Impact of non-adherence to direct oral anticoagulants amongst Swedish patients with non-valvular atrial fibrillation: results from a real-world cost-utility analysis

Journal of medical economics, 2022, Vol.25 (1), p.1085-1091

2022

Link zum Volltext

Verfügbarkeit prüfen

Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes

The New England journal of medicine, 2023-09, Vol.389 (13), p.1167-1179

2023

Link zum Volltext

Verfügbarkeit prüfen

Cardiac Arrhythmias in Patients with Chronic Kidney Disease: Implications of Renal Failure for Antiarrhythmic Drug Therapy

Current medicinal chemistry, 2016-01, Vol.23 (19), p.2070

2016

Link zum Volltext

Verfügbarkeit prüfen

Supraventricular Arrhythmias in Patients with Adult Congenital Heart Disease

Arrhythmia & electrophysiology review, 2017-06, Vol.6 (2), p.42-49

2017

Link zum Volltext

Verfügbarkeit prüfen

What are the costs of atrial fibrillation?

Europace (London, England), 2011-05, Vol.13 Suppl 2 (suppl 2), p.ii9-ii12

2011

Link zum Volltext

Verfügbarkeit prüfen

Contemporary management of patients undergoing atrial fibrillation ablation: in-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry

European heart journal, 2017-05, Vol.38 (17), p.1303-1316

2017

Link zum Volltext

Verfügbarkeit prüfen

Repolarization abnormalities unmasked with a 252‐lead BSM system in patients with ARVC and healthy gene carriers

Pacing and clinical electrophysiology, 2022-04, Vol.45 (4), p.509-518

2022

Link zum Volltext

Verfügbarkeit prüfen

Screening and risk evaluation for sudden cardiac death in ischaemic and non-ischaemic cardiomyopathy: results of the European Heart Rhythm Association survey

Europace (London, England), 2013-07, Vol.15 (7), p.1059-1062

2013

Link zum Volltext

Verfügbarkeit prüfen

2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy

Kardiologia polska (1957), , Vol.77 (3), p.245-326

Link zum Volltext

Verfügbarkeit prüfen

The European Lead Extraction ConTRolled (ELECTRa) study: a European Heart Rhythm Association (EHRA) Registry of Transvenous Lead Extraction Outcomes

European heart journal, 2017-10, Vol.38 (40), p.2995-3005

2017

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death : proposal for a common European protocol : Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology

European heart journal, 2005-03, Vol.26 (5), p.516-524

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 374

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(358)
Mit Volltextzugriff
(363)

Publikationsform

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(245)
Life Sciences & Biomedicine
(244)
Cardiovascular System & Cardiology
(229)
Cardiac & Cardiovascular Systems
(228)
Humans
(226)
Cardiology
(138)
Kardiologi
(134)
Atrial Fibrillation
(102)
Female
(94)
Male
(89)
Aged
(64)
Middle Aged
(63)
Treatment Outcome
(61)
Medicine
(53)
Risk Factors
(51)
Europe
(49)
Atrial Fibrillation - Diagnosis
(48)
Medicin
(45)
Cardiology And Cardiovascular Medicine
(41)
Catheter Ablation
(40)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The 4S-AF Scheme (Stroke Risk; Symptoms; Severity of Burden; Substrate): A Novel Approach to In-Depth Characterization (Rather than Classification) of Atrial Fibrillation

Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE

CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients—who is doing what to whom and how?

Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force

Atrial fibrillation history impact on catheter ablation outcome

Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement

The wearable cardioverter-defibrillator: current technology and evolving indications

Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE

Comparison of outcomes in infected cardiovascular implantable electronic devices between complete, partial, and failed lead removal: an ESC-EHRA-EORP ELECTRa (European Lead Extraction ConTrolled) registry

Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE)

Thoracoscopic epicardial left atrial ablation in symptomatic patients with atrial fibrillation

Programmed ventricular stimulation early after myocardial infarction: authors' reply

Impact of non-adherence to direct oral anticoagulants amongst Swedish patients with non-valvular atrial fibrillation: results from a real-world cost-utility analysis

Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes

Cardiac Arrhythmias in Patients with Chronic Kidney Disease: Implications of Renal Failure for Antiarrhythmic Drug Therapy

Supraventricular Arrhythmias in Patients with Adult Congenital Heart Disease

What are the costs of atrial fibrillation?

Contemporary management of patients undergoing atrial fibrillation ablation: in-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry

Repolarization abnormalities unmasked with a 252‐lead BSM system in patients with ARVC and healthy gene carriers

Screening and risk evaluation for sudden cardiac death in ischaemic and non-ischaemic cardiomyopathy: results of the European Heart Rhythm Association survey

2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy

The European Lead Extraction ConTRolled (ELECTRa) study: a European Heart Rhythm Association (EHRA) Registry of Transvenous Lead Extraction Outcomes

Suchergebnisse filtern